Zacks Investment Research upgraded shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) from a hold rating to a buy rating in a research report report published on Tuesday morning. Zacks Investment Research currently has $24.00 price target on the real estate investment trust’s stock.

According to Zacks, “Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in real estate serving the healthcare industry. The trust owns nursing homes, rehabilitation centers, assisted living facilities, and independent living centers. It leases properties to tenants and operators throughout the United States. Sabra Health Care REIT, Inc. is based in Irvine, California. “

A number of other equities analysts have also recently issued reports on SBRA. Cantor Fitzgerald restated a buy rating and set a $30.00 price target on shares of Sabra Healthcare REIT in a report on Monday, May 8th. Canaccord Genuity reissued a hold rating and issued a $26.00 price target on shares of Sabra Healthcare REIT in a research report on Tuesday, May 9th. Jefferies Group LLC reissued a hold rating and issued a $28.00 price target on shares of Sabra Healthcare REIT in a research report on Friday, May 12th. BidaskClub raised Sabra Healthcare REIT from a sell rating to a hold rating in a research report on Tuesday, June 20th. Finally, Mizuho reaffirmed a neutral rating on shares of Sabra Healthcare REIT in a research report on Wednesday, June 28th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. Sabra Healthcare REIT has an average rating of Hold and a consensus price target of $25.67.

Sabra Healthcare REIT (NASDAQ:SBRA) opened at 22.24 on Tuesday. The company has a market cap of $1.46 billion, a price-to-earnings ratio of 18.72 and a beta of 0.89. The company’s 50-day moving average is $22.50 and its 200 day moving average is $24.86. Sabra Healthcare REIT has a 1-year low of $19.30 and a 1-year high of $29.10.

WARNING: “Zacks Investment Research Upgrades Sabra Healthcare REIT, Inc. (SBRA) to “Buy”” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/02/zacks-investment-research-upgrades-sabra-healthcare-reit-inc-sbra-to-buy.html.

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 18th. Investors of record on Wednesday, August 16th were issued a dividend of $0.3599 per share. The ex-dividend date of this dividend was Monday, August 14th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 6.47%. Sabra Healthcare REIT’s dividend payout ratio is 122.03%.

A number of institutional investors have recently made changes to their positions in SBRA. Albert D Mason Inc. boosted its position in shares of Sabra Healthcare REIT by 1.1% in the first quarter. Albert D Mason Inc. now owns 29,595 shares of the real estate investment trust’s stock worth $827,000 after buying an additional 315 shares during the period. LSV Asset Management boosted its position in shares of Sabra Healthcare REIT by 45.5% in the first quarter. LSV Asset Management now owns 2,778,914 shares of the real estate investment trust’s stock worth $77,615,000 after buying an additional 868,441 shares during the period. Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of Sabra Healthcare REIT by 0.7% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 62,551 shares of the real estate investment trust’s stock worth $1,747,000 after buying an additional 421 shares during the period. Great West Life Assurance Co. Can boosted its position in shares of Sabra Healthcare REIT by 6.6% in the first quarter. Great West Life Assurance Co. Can now owns 93,954 shares of the real estate investment trust’s stock worth $2,621,000 after buying an additional 5,841 shares during the period. Finally, Geneva Advisors LLC bought a new position in shares of Sabra Healthcare REIT during the first quarter worth approximately $1,035,000. 99.26% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Get a free copy of the Zacks research report on Sabra Healthcare REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Stock Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related stocks with our FREE daily email newsletter.